Headlines about RTI Surgical (NASDAQ:RTIX) have trended somewhat positive on Wednesday, Accern Sentiment Analysis reports. Accern identifies negative and positive media coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. RTI Surgical earned a media sentiment score of 0.02 on Accern’s scale. Accern also assigned press coverage about the medical equipment provider an impact score of 46.1220857831323 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
A number of equities research analysts have recently issued reports on the stock. Zacks Investment Research lowered shares of RTI Surgical from a “hold” rating to a “sell” rating in a report on Tuesday, March 6th. BidaskClub lowered shares of RTI Surgical from a “hold” rating to a “sell” rating in a report on Tuesday, December 5th. Finally, Craig Hallum raised shares of RTI Surgical from a “hold” rating to a “buy” rating in a research report on Friday, March 2nd. Two investment analysts have rated the stock with a sell rating, one has assigned a hold rating and one has given a buy rating to the stock. RTI Surgical presently has a consensus rating of “Hold”.
RTI Surgical (NASDAQ:RTIX) opened at $4.80 on Wednesday. The company has a current ratio of 3.50, a quick ratio of 1.39 and a debt-to-equity ratio of 0.23. The firm has a market cap of $304.38, a PE ratio of 80.83, a PEG ratio of 2.31 and a beta of 1.69. RTI Surgical has a 1 year low of $3.58 and a 1 year high of $6.00.
RTI Surgical Company Profile
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.